135 related articles for article (PubMed ID: 11181500)
1. P450 enzyme expression patterns in the NCI human tumor cell line panel.
Yu LJ; Matias J; Scudiero DA; Hite KM; Monks A; Sausville EA; Waxman DJ
Drug Metab Dispos; 2001 Mar; 29(3):304-12. PubMed ID: 11181500
[TBL] [Abstract][Full Text] [Related]
2. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
3. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.
Fitzsimmons SA; Workman P; Grever M; Paull K; Camalier R; Lewis AD
J Natl Cancer Inst; 1996 Mar; 88(5):259-69. PubMed ID: 8614004
[TBL] [Abstract][Full Text] [Related]
4. Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase.
Patten CJ; Peterson LA; Murphy SE
Drug Metab Dispos; 1998 Feb; 26(2):177-80. PubMed ID: 9456305
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
6. Comparison of maturation of drug-metabolizing enzymes in calves with functioning or nonfunctioning rumen.
Kawalek JC; el Said KR
Am J Vet Res; 1994 Nov; 55(11):1579-86. PubMed ID: 7879982
[TBL] [Abstract][Full Text] [Related]
7. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770
[TBL] [Abstract][Full Text] [Related]
8. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
9. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
[TBL] [Abstract][Full Text] [Related]
10. Two cytochrome P-450 isoforms catalysing O-de-ethylation of ethoxycoumarin and ethoxyresorufin in higher plants.
Werck-Reichhart D; Gabriac B; Teutsch H; Durst F
Biochem J; 1990 Sep; 270(3):729-35. PubMed ID: 2241905
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues.
Schwartzman ML; Masferrer J; Dunn MW; McGiff JC; Abraham NG
Curr Eye Res; 1987 Apr; 6(4):623-30. PubMed ID: 3107908
[TBL] [Abstract][Full Text] [Related]
12. Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice.
Liu J; Liu Y; Parkinson A; Klaassen CD
J Pharmacol Exp Ther; 1995 Nov; 275(2):768-74. PubMed ID: 7473165
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
14. Bromopropylate: induction of hepatic cytochromes P450 and absence of covalent binding to DNA in mouse liver.
Thomas H; Sagelsdorff P; Molitor E; Skripsky T; Waechter F
Toxicol Appl Pharmacol; 1994 Nov; 129(1):155-62. PubMed ID: 7974489
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
16. Peroxide-supported in-vitro cytochrome P450 activities in Haemonchus contortus.
Kotze AC
Int J Parasitol; 1999 Mar; 29(3):389-96. PubMed ID: 10333321
[TBL] [Abstract][Full Text] [Related]
17. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
Lengler J; Omann M; Düvier D; Holzmüller H; Gregor W; Salmons B; Günzburg WH; Renner M
Biochem Pharmacol; 2006 Sep; 72(7):893-901. PubMed ID: 16887103
[TBL] [Abstract][Full Text] [Related]
19. Anti-P450lpr antiserum inhibits specific monooxygenase activities in LPR house fly microsomes.
Wheelock GD; Scott JG
J Exp Zool; 1992 Nov; 264(2):153-8. PubMed ID: 1431777
[TBL] [Abstract][Full Text] [Related]
20. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
